Sepsis Diagnostics Market Size to Surpass USD 1582.23 Million by 2030 at 9.80% CAGR – Report by Market Research Future (MRFR)

Sepsis Diagnostics Market Trends and Insights By Technology (Molecular Diagnostics, Biomarkers, Immunoassays and others), Type of Product (Kits, Instruments, Blood Culture Media and others), End Users (Pathology Laboratories, Specialty Clinics, Hospitals, Diagnostic Centers and others), Competitive Market Growth, Size, Share and Forecast to 2030

New York, USA, Feb. 02, 2023 (GLOBE NEWSWIRE) — Sepsis Diagnostics Market Overview

According to a Comprehensive Research Report by Market Research Future (MRFR), “Sepsis Diagnostics Market Information By Technology, Type of Product, End Users And Region – Forecast till 2030“, the market is expected to gain a market value of USD 1,582.23 million by 2030 at a CAGR of 9.80% over the forecast period of 2022-2030.

Market Synopsis

Sepsis is a potentially fatal condition resulting from the body’s immune system attacking its own tissues in response to an infection. Organs perform badly and inappropriately when the body’s infection-fighting mechanisms are activated. As a result of the body’s immune system attacking its tissues in response to an infection, sepsis is potentially lethal. Organs perform badly and inappropriately when the body’s infection-fighting mechanisms are activated. Sepsis can lead to septic shock. This unexpected drop in blood pressure can seriously harm organs and even result in death. The likelihood of survival is improved by receiving intravenous fluids and antibiotics as soon as feasible. With the creation and introduction of such sophisticated, fast testing, major industry participants would have profitable prospects to improve their market position. Over the forecast period, the rising approval process and the launch of technologically sophisticated diagnostic solutions are anticipated to be the key drivers of market expansion.

Nosocomial infections, sometimes called hospital-acquired infections or HAIs, are a major cause of morbidity and mortality worldwide. The most common hospital-acquired infections are urinary tract infections, bronchitis, and sepsis (HAIs). Due to the rising incidence of sepsis and the growing global geriatric population, sepsis diagnosis is anticipated to have considerable market expansion throughout the predicted period. Increased government support for sepsis-related research initiatives and an increase in the prevalence of infectious diseases are the main drivers fueling the market’s expansion.

Get Free Sample PDF Brochure @

Report Scope:

Report Attribute Details
Market Size in 2030 USD 1582.23 Million
CAGR 9.80%
Base Year 2021
Forecast Period 2022-2030
Historical Data 2020
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Technology, Type of Product and End User
Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Market Drivers Rising prevalence of sepsis has led to a growing need for its early diagnosis
The increasing awareness for healthcare and the population of the older generation is depicted to offer new opportunities

Competitive Landscape:

The notable contenders in the sepsis diagnostics market are:

  • Scotland (US)
  • Beckmam Coulter Inc. (US)
  • Hoffman-La Roche AG (Switzerland)
  • Luminex Corporation (US)
  • Axis-Shield Diagnostics Ltd. (Scotland)
  • Becton Dickinson and Company (US)
  • EKF Diagnostics (UK)
  • Cube Dx GmbH (Austria)
  • Wolters Kulwer N.V. (Netherlands)
  • Amara Health (US)
  • Alpa Laboratories Ltd. (India)
  • Sandstone Diagnostics Inc. (US)
  • T2 Biosystems, Inc. (US)
  • Immunexpress (US)
  • Abbott Laboratories (US)
  • CytoSorbents Corporation(US)
  • EKF Diagnostics (UK)

Sepsis Diagnostics Market Dynamics:

Market Drivers:

Healthcare organizations and institutions have been conducting research and development due to the challenge of identifying sepsis. Sepsis is a very challenging illness to identify. As a result, the market for sepsis diagnostics is anticipated to grow in the future years. On the other hand, throughout the projection period, it is projected that the development of quick diagnosis/point-of-care) approaches for early sepsis diagnostics will offer profitable prospects to the leading market players. The prevalence of hospital-acquired infections, the number of pneumonia cases, the prevalence of sepsis, the growing number of sepsis operations, and an increase in financing for sepsis-related scientific research are the main drivers of the expansion of the sepsis diagnostics market.

As a result, there is a greater requirement for the early detection of sepsis to prevent patients from delaying antibiotic therapy. Over the forecast period, rising regulatory approval and the launch of technologically sophisticated diagnostic solutions are anticipated to be the key drivers of market expansion. As a result, producers of sepsis diagnostics are rapidly expanding the range of point-of-care technologies they provide, which aid in the early detection and speed up diagnosis overall. Sepsis’s rise and the introduction of technologically enhanced diagnostic systems that provide real-time insights and track patient health are driving the market’s expansion. Additionally, elements like the high occurrence of sepsis and growing awareness are anticipated to boost the market substantially.

Market Restraints:

Government hospitals, particularly those in developing nations, and academic research labs cannot accommodate such systems due to funding restrictions, despite sepsis diagnostics companies focusing on developing automated diagnostic tools for identifying sepsis based on cutting-edge technologies like sepsis molecularly diagnostics. Additionally, it is increasingly posing a substantial barrier to expanding the market for sepsis diagnostics equipment. Unfortunately, there is a major shortage of qualified experts worldwide; only about half of patients with severe sepsis transported by the EMS system have a paramedic with them. All aspects of patient care, particularly sepsis awareness, assessing patients for the existence of sepsis diagnostic equipment, and making appropriate treatment decisions, are impacted by the lack of skilled paramedics. However, the market is constrained by expensive automated diagnostics devices.

Browse In-depth Market Research Report (85 Pages) on Sepsis Diagnostics:

COVID 19 Analysis

Revenue of sepsis diagnostics increased as a result of the COVID-19 epidemic. Sepsis detection tools, reagents, and test kits are expected to be more quickly adopted due to the COVID-19 pandemic’s rapid global spread and the rise of sepsis occurrences among COVID-19 patients. The dangers that older people confront have come to light due to the current global crisis. Older people are more susceptible to complications like acute respiratory distress syndrome (ARDS), typically brought on by pneumonia and an increased risk of sepsis. Therefore, the need for early sepsis diagnosis in individuals with COVID-19 infections is increased. Because so many persons contracted COVID-19 during the epidemic, the rate of hospitalizations rose. As a result, most patients developed sepsis while being treated in hospitals. The number of surgeries and hospital-borne illnesses across all age groups positively impacts the sepsis diagnostics market.

Buy Now:

Sepsis Diagnostics Market Segmentation

By end users, the market includes pathology laboratories, specialty clinics, hospitals, and diagnostic centers.

By technology, the market includes molecular diagnostics, biomarkers, and immunoassays.

The market includes kits, instruments, and blood culture media by type of product.

Sepsis Diagnostics Market Regional Insights

The forecast period is expected to see the biggest share in North America. It is primarily due to the region’s developed medical services and supply infrastructure. Additionally, the market growth is favored by the rising implementation of cutting-edge technology for sepsis diagnosis. Additionally, the market will benefit from growing investments in the areas of research and innovation for the diagnosis of sepsis. Additionally, it is estimated that Europe now holds the second-largest market share for sepsis diagnostics.

Share your Queries @

The market will benefit from the expanding use of technological advances and investments in research & development from various economies. It is projected that a highly developed health service, high adoption of cutting-edge sepsis diagnostics technology, and scientific innovation in the field of sepsis diagnostics will fuel the market growth. According to estimates, Asia-Pacific has the fastest market growth. Due to the increased need for sepsis diagnostic solutions in nations with a high frequency of infectious diseases, Middle East Africa is also anticipated to have considerable growth over the forecast period.

Discover more research Reports on Healthcare Industry by Market Research Future:

Molecular Diagnostics Market Research Report: Information By Product (Reagents & Kits, Instruments and Services & Software), Technique (Polymerase Chain Reaction (PCR), Isothermal Amplification, Hybridization, Sequencing, Microarray and others), Application (Infectious Diseases, Oncology, Genetic Tests and others), End User (Hospitals & Clinics, Diagnostic Laboratories and others) – Forecast till 2030

Biomarkers Market Information By Product (Consumables, Services, Software), By Type (Safety Biomarkers, Validation Biomarkers, Efficacy Biomarkers), By Application (Diagnostics, Personalized Medicine, Drug Discovery and Development, Disease Risk Assessment) and By Disease Indication (Cancer, Neurological Disorders, Cardiovascular Disorders, Immunological Disorders, Others) – Forecast till 2030

Immunoassay Market Research Report: by Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Technology [Radioimmunoassay (RIA), Enzyme-linked Immunosorbent Assay (ELISA), Enzyme-linked Fluorescent Assay (ELFA), Chemiluminescence Immunoassay (CLIA), Rapid Test, Others], Indication (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Diseases, Autoimmune Diseases, Others), End User (Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others) and Region – Forecast till 2027

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

CONTACT: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: [email protected] Website:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.